Gapping up
In reaction to strong earnings/guidance:
- TSLA +7.7% (reports record Q2 deliveries, above estimates; orders exceeded deliveries), JEF +2.7%
M&A news:
- OMN +54.5% (to be acquired by Synthomer plc for $10.15/share in cash)
- SYMC +17.4% (Broadcom (AVGO) in advanced discussions to acquire SYMC, according to Bloomberg) .
Select metals/mining stocks trading higher:
- AU +2.3%, GFI +1.7%, GOLD +1.5%, GDX +0.6%, GLD +0.5%, BHP +0.5%
Other news:
- LCI +3.7% (FDA denies Citizen Petition submitted by Genus Lifesciences requesting that the agency refuse to accept any submissions related to Lannett's 505(b)(2) New Drug Application (NDA) for Cocaine Hydrochloride Topical Solution, 4% and 10%)
- SALT +3% (President buys 125K of co's common stock; note: yesterday, shares of SALT rose over 10% on no news)
- CTST +2.4% (provides update on outdoor cultivation and first shipment to Australia)
- LOGI +1.3% (elected Wendy Becker as Logitech's new chairperson and proposes dividend increase)
- GSK +1.2% (GlaxoSmithKline/Pfizer (PFE): ViiV Healthcare EU granted Marketing Authorisation for Dovato (dolutegravir/lamivudine) for the treatment of HIV-1 infection in adults and adolescents above 12 years of age)
- BIDU +1% (will provide updates to its businesses at the AI Developer Conference today - will include that June average DAUs of Baidu App reached 188 million)
- ABUS +0.9% (Arbutus Biopharma sells part of its royalty interest on future global net sales of ONPATTRO, an RNA interference (RNAi) therapeutic currently being sold by Alnylam Pharma (ALNY), to OMERS, the defined benefit pension plan for municipal employees in Ontario, Canada)
Analyst comments:
- GOL +0.7% (upgraded to Buy from Neutral at Goldman)